E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein

Journal of Virology

Volumn 81, Issue 3, 2007, Pages 1379-1389

  Handa, Keisuke ^a,c   Yugawa, Takashi ^a   Narisawa Saito, Mako ^a   Ohno, Shin Ichi ^a   Fujita, Masatoshi ^a   Kiyono, Tohru ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Health Sciences University of Hokkaido ^*  (Japan)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DROSOPHILA PROTEIN; MESSENGER RNA; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN DLG4; PROTEIN E6; PROTEIN E7; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CARCINOGENICITY; CELL TRANSFORMATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HYPERPLASIA; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UTERINE CERVIX CANCER;

CELL LINE; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS;

BOVINE PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; MUS MUSCULUS; PAPILLOMAVIRIDAE; RODENTIA;

EID: 33846467609     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01712-06     Document Type: Article

References (43)

1. Christopherson, K. S., B. J. Hillier, W. A. Lim, and D. S. Bredt. 1999. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274:27467-27473.
2. Dostatni, N., P. F. Lambert, R. Sousa, J. Ham, P. M. Howley, and M. Yaniv. 1991. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 5:1657-1671.
3. Dowhanick, J. J., A. A. McBride, and P. M. Howley. 1995. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69:7791-7799.
4. El-Husseini, A. E., E. Schnell, D. M. Chetkovich, R. A. Nicoll, and D. S. Bredt. 2000. PSD-95 involvement in maturation of excitatory synapses. Science 290:1364-1368.
5. Favre-Bonvin, A., C. Reynaud, C. Kretz-Remy, and P. Jalinot. 2005. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome. J. Virol. 79:4229-4237.
6. Frese, K. K., I. J. Latorre, S. H. Chung, G. Caruana, A. Bernstein, S. N. Jones, L. A. Donehower, M. J. Justice, C. C. Garner, and R. T. Javier. 2006. Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor. EMBO J. 25:1406-1417.
7. Gardiol, D., C. Kuhne, B. Glaunsinger, S. S. Lee, R. Javier, and L. Banks. 1999. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18:5487-5496.
8. Gewin, L., H. Myers, T. Kiyono, and D. A. Galloway. 2004. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18:2269-2282.
9. Glaunsinger, B. A., S. S. Lee, M. Thomas, L. Banks, and R. Javier. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280.
10. Grm, H. S., and L. Banks. 2004. Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent. J. Gen. Virol. 85:2815-2819.
11. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775-784.
12. Im, Y. J., J. H. Lee, S. H. Park, S. J. Park, S. H. Rho, G. B. Kang, E. Kim, and S. H. Eom. 2003. Crystal structure of the Shank PDZ-ligand complex reveals a class I PDZ interaction and a novel PDZ-PDZ dimerization. J. Biol. Chem. 278:48099-48104.
13. 0/G1 to S phase. Oncogene 19:365-372.
14. Jelen, F., A. Oleksy, K. Smietana, J. Otlewski, Y. J. Im, J. H. Lee, S. H. Park, S. J. Park, S. H. Rho, G. B. Kang, E. Kim, S. H. Eom, C. Nourry, S. G. Grant, J. P. Borg, K. S. Christopherson, B. J. Hillier, W. A. Lim, and D. S. Bredt. 2003. PDZ domains-common players in the cell signaling. Acta Biochim. Pol. 50:985-1017.
15. Kao, W. H., S. L. Beaudenon, A. L. Talis, J. M. Huibregtse, and P. M. Howley. 2000. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 74:6408-6417.
16. Kiyono, T., A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:11612-11616.
17. Kolly, C., M. M. Suter, and E. J. Muller. 2005. Proliferation, cell cycle exit, and onset of terminal differentiation in cultured keratinocytes: pre-programmed pathways in control of C-Myc and Notch1 prevail over extracellular calcium signals. J. Investig. Dermatol. 124:1014-1025.
18. Kornau, H. C., L. T. Schenker, M. B. Kennedy, and P. H. Seeburg. 1995. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269:1737-1740.
19. Kyo, S., M. Nakamura, T. Kiyono, Y. Maida, T. Kanaya, M. Tanaka, N. Yatabe, and M. Inoue. 2003. Successful immortalization of endometrial glandular cells with normal structural and functional characteristics. Am. J. Pathol. 163:2259-2269.
20. Lee, S. S., B. Glaunsinger, F. Mantovani, L. Banks, and R. T. Javier. 2000. Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74:9680-9693.
21. Lee, S. S., R. S. Weiss, and R. T. Javier. 1997. Binding of human virus oncoproteins to hDLG/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:6670-6675.
22. Makino, K., H. Kuwahara, N. Masuko, Y. Nishiyama, T. Morisaki, J. Sasaki, M. Nakao, A. Kuwano, M. Nakata, Y. Ushio, and H. Saya. 1997. Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Oncogene 14:2425-2433.
23. Massimi, P., N. Gammoh, M. Thomas, and L. Banks. 2004. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene 23:8033-8039.
24. Matsumine, A., A. Ogai, T. Senda, N. Okumura, K. Satoh, G. H. Baeg, T. Kawahara, S. Kobayashi, M. Okada, K. Toyoshima, and T. Akiyama. 1996. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science 272:1020-1023.
25. Matsumoto, Y., S. Nakagawa, T. Yano, S. Takizawa, K. Nagasaka, K. Nakagawa, T. Minaguchi, O. Wada, H. Ooishi, K. Matsumoto, T. Yasugi, T. Kanda, J. M. Huibregtse, and Y. Taketani. 2006. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. J. Med. Virol. 78:501-507.
26. Migaud, M., P. Charlesworth, M. Dempster, L. C. Webster, A. M. Watabe, M. Makhinson, Y. He, M. F. Ramsay, R. G. Morris, J. H. Morrison, T. J. O'Dell, and S. G. Grant. 1998. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396:433-439.
27. Nakagawa, S., and J. M. Huibregtse. 2000. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20:8244-8253.
28. Nakamura, H., H. Fukami, Y. Hayashi, T. Kiyono, S. Nakatsugawa, M. Hamaguchi, and K. Ishizaki. 2002. Establishment of immortal normal and ataxia telangiectasia fibroblast cell lines by introduction of the hTERT gene. J. Radiat. Res. (Tokyo) 43:167-174.
29. Naviaux, R. K., E. Costanzi, M. Haas, and I. M. Verma. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705.
30. Nguyen, M. L., M. M. Nguyen, D. Lee, A. E. Griep, and P. F. Lambert. 2003. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77:6957-6964.
31. Nourry, C., S. G. Grant, and J. P. Borg. 2003. PDZ domain proteins: plug and play! Sci. STKE 2003:RE7.
32. Ohshiro, T., T. Yagami, C. Zhang, and F. Matsuzaki. 2000. Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast. Nature 408:593-596.
33. Peng, C. Y., L. Manning, R. Albertson, and C. Q. Doe. 2000. The tumour-suppressor genes Ig1 and dlg regulate basal protein targeting in Drosophila neuroblasts. Nature 408:596-600.
34. Pim, D., M. Thomas, R. Javier, D. Gardiol, and L. Banks. 2000. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19:719-725.
35. Romanczuk, H., F. Thierry, and P. M. Howley. 1990. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64:2849-2859.
36. Sawada, M., T. Kiyono, S. Nakashima, J. Shinoda, T. Naganawa, S. Hara, T. Iwama, and N. Sakai. 2004. Molecular mechanisms of TNF-alpha-induced ceramide formation in human glioma cells:P53-mediated oxidant stress-dependent and -independent pathways. Cell Death Differ. 11:997-1008.
37. Scheffner, M., J. M. Huibregtse, and P. M. Howley. 1994. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. USA 91:8797-8801.
38. Stathakis, D. G., K. B. Hoover, Z. You, and P. J. Bryant. 1997. Human postsynaptic density-95 (PSD95): location of the gene (DLG4) and possible function in nonneural as well as in neural tissues. Genomics 44:71-82.
39. Thomas, M., B. Glaunsinger, D. Pim, R. Javier, and L. Banks. 2001. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 20:5431-5439.
40. Thomas, M., R. Laura, K. Hepner, E. Guccione, C. Sawyers, L. Lasky, and L. Banks. 2002. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21:5088-5096.
41. Thomas, M., P. Massimi, C. Navarro, J. P. Borg, and L. Banks. 2005. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24:6222-6230.
42. Watson, R. A., M. Thomas, L. Banks, and S. Roberts. 2003. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J. Cell Sci. 116:4925-4934.
43. Zhou, C., and B. Blumberg. 2003. Overlapping gene structure of human VLCAD and DLG4. Gene 305:161-166.